Skip to content

A randomized controlled trial on effect of computerized cognitive remediation therapy on cognitive function and relapse in alcohol-dependent patients

A randomized controlled trial on effect of computerized cognitive remediation therapy on cognitive function and relapse in alcohol-dependent patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059805
Enrollment
Unknown
Registered
2022-05-11
Start date
2022-09-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol dependence

Interventions

CCRT group:Computerized cognitive remediation therapy and usual care
Control Group:Usual care

Sponsors

The Second Affiliated Hospital of Xinxiang Medical College
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Subjects meeting DSM-5 diagnostic criteria for alcohol use disorders, 2. Age 18-60 years old, right handed subject; 3. Color vision, vision and hearing were normal or normal after correction; 4. Junior high school education or above, can use or learn to use computer software; 5. No obvious symptoms of physical abstinence; 6. Be able to cooperate with CCRT treatment, agree to complete follow-up evaluation, and voluntarily sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe somatic and brain organic diseases; 2. Mental retardation; 3. Suffer from other mental diseases that affect cognitive function (such as schizophrenia, mood disorders, etc.)

Design outcomes

Primary

MeasureTime frame
Cognitive function;Thirst;

Secondary

MeasureTime frame
Depression;Anxiety;Compulsiveness;

Countries

China

Contacts

Public ContactPing Cui

The Second Affiliated Hospital of Xinxiang Medical College

546977850@qq.com+86 15837341597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026